Financial statements Alivia - Onkologiczna
Balance sheet of Alivia - Onkologiczna
Company age:
Age:
15 y. 5 m. 29 d.
Balance sheet data of ALIVIA - ONKOLOGICZNA
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 14 447 336,14 | 15 550 701,12 |
| A. Fixed assets | 10 416 292,97 | 9 590 250,61 |
| B. Current assets | 4 031 043,17 | 5 960 450,51 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - |
| Total liabilities | 14 447 336,14 | 15 550 701,12 |
| A. Equity | 4 529 397,33 | 5 545 136,32 |
| B. Liabilities and provisions for liabilities | 9 917 938,81 | 10 005 564,80 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 521 514,43 | 309 382,85 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.